Follicular Lymphoma
📧 Sign up to get email alerts when something new happens for Follicular Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-01-10Clinical Trial Update: A Phase 1/2 Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating Betalutin in relapsed non-Hodgkin lymphoma has completed. The study included follicular lymphoma, with r…
-
CLINICAL_TRIALS trial_result · 2024-01-03Clinical Trial Update: Open-Label Study of Parsaclisib, in Japanese Participants With Relapsed or Refractory Follicular Lymphoma (CITADEL-213) [Phase 2]
Open-label Phase 2 study of parsaclisib in Japanese participants with relapsed or refractory follicular lymphoma (CITADEL-213); results from…
-
CLINICAL_TRIALS trial_result · 2023-12-26Clinical Trial Update: A Study of Obinutuzumab, Polatuzumab Vedotin, and Lenalidomide in Relapsed or Refractory Follicular Lymphoma (FL) and Rituximab in Combination With Polatuzumab Vedotin and Lenalidomide in Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) [Phase 1, Phase 2]
Phase 1/2 trial evaluating obinutuzumab, polatuzumab vedotin, and lenalidomide in relapsed or refractory follicular lymphoma and rituximab w…
-
CLINICAL_TRIALS trial_result · 2023-12-22Clinical Trial Update: Study of Safety and Efficacy of Betalutin and Rituximab in Patients With FL [Phase 1]
Phase 1 clinical trial update on safety and efficacy of betalutin with rituximab in follicular lymphoma, completed with posted results in 20…
-
CLINICAL_TRIALS trial_result · 2023-12-14Clinical Trial Update: A Phase III Multicenter, Randomized Study Comparing RIT Vs ASCT in Patients With Relapsed/Refractory (FL) [Phase 3]
A Phase III multicenter randomized trial comparing RIT versus ASCT in relapsed/refractory follicular lymphoma; status and results are not pr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-12-13Clinical Trial Update: Phase 3 Study of Zandelisib (ME-401) in Combination With Rituximab in Patients With iNHL - (COASTAL) [Phase 3]
Phase 3 trial COASTAL evaluating Zandelisib in combination with Rituximab in indolent non-Hodgkin lymphoma was terminated; results were post…
-
CLINICAL_TRIALS trial_result · 2023-12-05Clinical Trial Update: Revlimid Dose 25 mg in Association With (R-CHOP) in the Treatment Follicular Lymphoma [Phase 2]
Phase 2 trial investigating Revlimid (lenalidomide) at 25 mg with R-CHOP in follicular lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2023-11-24Clinical Trial Update: CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Non-Hodgkins Lymphoma [Phase 2]
Phase 2 trial update for CD19-targeted CAR T cells in relapsed/refractory non-Hodgkin lymphoma, including DLBCL and follicular lymphoma, wit…
-
CLINICAL_TRIALS trial_result · 2023-11-21Clinical Trial Update: SYMPHONY-2, A Trial to Examine Combination of Tazemetostat With Rituximab in Subjects With Relapsed/Refractory Follicular Lymphoma [Phase 2]
Phase 2 trial evaluating combination of tazemetostat with rituximab in relapsed/refractory follicular lymphoma was terminated.
-
CLINICAL_TRIALS trial_result · 2023-11-09Clinical Trial Update: Ublituximab Followed by Response-driven Addition of Umbralisib for Treatment-naive Follicular or Marginal Zone Lymphoma [Phase 2]
Phase 2 trial evaluating ublituximab followed by response-driven addition of umbralisib for treatment-naive follicular lymphoma or marginal …
-
CLINICAL_TRIALS trial_result · 2023-10-23Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Loncastuximab Tesirine Versus Idelalisib in Participants With Relapsed or Refractory Follicular Lymphoma [Phase 2]
Phase 2 trial comparing Loncastuximab Tesirine to Idelalisib in relapsed or refractory follicular lymphoma was terminated with posted result…
-
CLINICAL_TRIALS trial_result · 2023-10-10Clinical Trial Update: A Study of Obinutuzumab, Rituximab, Polatuzumab Vedotin, and Venetoclax in Relapsed or Refractory Follicular Lymphoma (FL) or Diffuse Large B-Cell Lymphoma (DLBCL) [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluating obinutuzumab, rituximab, polatuzumab vedotin, and venetoclax in relapsed/refractory follicular lympho…
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Allo HSCT Using RIC for Hematological Diseases [Phase 2]
Phase 2 trial evaluating allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning for various hematologic dise…
-
CLINICAL_TRIALS trial_result · 2023-08-14Clinical Trial Update: Dose Optimization Study of Idelalisib in Follicular Lymphoma [Phase 3]
Phase 3 dose optimization study of idelalisib in follicular lymphoma has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2023-08-04Clinical Trial Update: Study of Tazemetostat as Single Agent in Solid Tumors or B-cell Lymphomas and in Combination With Prednisolone in DLBCL [Phase 1, Phase 2]
Clinical trial update for tazemetostat as a single agent and in combination in B-cell lymphomas and solid tumors completed with results post…
-
CLINICAL_TRIALS trial_result · 2023-07-25Clinical Trial Update: Autologous Cells Derived Anti-CD19 CAR-Engineered T Cells With Concurrent BTK Inhibitor for B Cell Lymphoma [Phase 3]
Phase 3 trial investigating autologous anti-CD19 CAR-T cells given with a BTK inhibitor for B cell lymphomas, with an unspecified status.
-
CLINICAL_TRIALS trial_result · 2023-07-24Clinical Trial Update: Study to Assess Umbralisib Plus Ublituximab in Participants With Treatment Naïve Follicular Lymphoma [Phase 2]
Phase 2 trial of umbralisib plus ublituximab in treatment-naïve follicular lymphoma was terminated; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-07-20Clinical Trial Update: Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant [Phase 1, Phase 2]
This update reports results from a Phase 1/2 clinical trial of a gene therapy for HIV-related lymphomas in patients undergoing stem cell tra…
-
CLINICAL_TRIALS trial_result · 2023-07-18Clinical Trial Update: Rituximab With or Without Yttrium Y-90 Ibritumomab Tiuxetan in Treating Patients With Untreated Follicular Lymphoma [Phase 3]
A phase 3 trial evaluating rituximab with or without Y-90 ibritumomab tiuxetan in untreated follicular lymphoma was terminated; results have…
-
CLINICAL_TRIALS trial_result · 2023-06-09Clinical Trial Update: High Dose Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil in Preventing Graft Versus Host Disease in Patients With Hematological Malignancies Undergoing Myeloablative or Reduced Intensity Donor Stem Cell Transplant [Phase 2]
Phase 2 clinical trial evaluating high-dose cyclophosphamide, tacrolimus, and mycophenolate mofetil to prevent graft-versus-host disease in …
-
CLINICAL_TRIALS trial_result · 2023-03-31Clinical Trial Update: First Line Therapy of Advanced Stage Follicular Lymphoma in Patients < 60 Years Not Eligible fo Standard Immunochemotherapy and in All Patients ≥ 60 Years [Phase 2]
Phase 2 trial update on first-line therapy for advanced Follicular Lymphoma in patients under 60 not eligible for standard immunochemotherap…
-
CLINICAL_TRIALS trial_result · 2023-03-21Clinical Trial Update: Pembrolizumab Alone or With Idelalisib or Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Non-Hodgkin Lymphomas [Phase 2]
Phase 2 trial of pembrolizumab alone or with idelalisib or ibrutinib in relapsed/refractory chronic lymphocytic leukemia or various low-grad…
-
CLINICAL_TRIALS trial_result · 2023-03-17Clinical Trial Update: Study of OBINUTUZUMAB Combined to LENALIDOMIDE for the Treatment of Relapsed/Refractory Follicular and Aggressive B-cell Lymphoma [Phase 1, Phase 2]
Clinical trial updates the combination of obinutuzumab with lenalidomide for relapsed/refractory follicular and aggressive B-cell lymphomas,…
-
CLINICAL_TRIALS trial_result · 2023-03-16Clinical Trial Update: TC-110 T Cells in Adults With Relapsed or Refractory Non-Hodgkin Lymphoma or Acute Lymphoblastic Leukemia [Phase 1, Phase 2]
Phase 1/2 trial update for TC-110 T cells in adults with relapsed or refractory non-Hodgkin lymphoma or acute lymphoblastic leukemia (comple…
-
CLINICAL_TRIALS trial_result · 2023-02-16Clinical Trial Update: Umbilical Cord Blood NK Cells, Rituximab, High-Dose Chemotherapy, and Stem Cell Transplant in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating Umbilical Cord Blood NK cells with Rituximab, high-dose chemotherapy, and stem cell transplant in recurrent or refr…